| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 18,056 | 17,311 | 17,232 | 16,278 | | Cost of Revenue | 6,006 | 6,567 | 6,189 | 5,758 | | | Gross Profit | 12,050 | 10,744 | 11,044 | 10,520 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,770 | 7,496 | 7,246 | 6,150 | | Non Recurring | (222) | 222 |
-
|
-
| | Others | 746 | 870 | 731 | 653 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,756 | 2,157 | 3,067 | 3,717 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 6 | (29) | 22 | | Earnings Before Interest And Taxes | 3,684 | 2,089 | 2,965 | 3,666 | | Interest Expense | 803 | 833 | 874 | 701 | | Income Before Tax | 2,881 | 1,256 | 2,091 | 2,965 | | Income Tax Expense | 1,038 | 465 | 648 | 1,136 | | Minority Interest | (74) | (74) | (74) | (73) | | | | Net Income From Continuing Ops | 1,843 | 791 | 1,443 | 1,829 | | | Non-recurring Events | | Discontinued Operations | (1,003) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 839 | 791 | 1,443 | 1,829 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $839 | $791 | $1,443 | $1,829 |
|
0.33% Nasdaq 
Income Statement
